Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry

EuroIntervention 2018;13:1603-1611 published online October 2017. DOI: 10.4244/EIJ-D-17-00076

Joelle Kefer
Joelle Kefer1*, MD, PhD; Adel Aminian2, MD; Paul Vermeersch3, MD, PhD; Tom de Potter4, MD; Francis Stammen5, MD; Edouard Benit6, MD; Werner Budts7, MD, PhD; Luc Missault8, MD, DSc; Benny Drieghe9, MD; Ian Buysschaert10, MD, PhD; Kristoff Cornelis11, MD; Jean-Manuel Herzet12, MD; Antoine Guedes13, MD, PhD; Nadia Debbas14, MD, PhD; Maximo Rivero15, MD; Mathieu Lempereur16, MD, PhD; Stijn Lochy17, MD; Ruben Casado-Arroyo18, MD; Christophe Laruelle
1. Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2. CHU Charleroi, Charleroi, Belgium; 3. Middelheim ZNA, Antwerp, Belgium; 4. OLV Ziekenhuis, Aalst, Belgium; 5. AZ Delta Roeselare, Roeselare, Belgium; 6. Jessaziekenhuis, Hasselt, Belgium; 7. Gas

Aims: This study aimed to assess the safety and efficacy at midterm follow-up of left atrial appendage occlusion (LAAO) using different devices, in real life in Belgium.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

atrial fibrillationbleedingspecific device closure/techniquestroke
Read next article
Left atrial appendage closure: size does matter!

Latest news